Adhesive Bandages Market to Record a CAGR of 4.26%, Growing Number of Surgical Procedures to Drive Growth - Technavio
NEW YORK, Sept. 1, 2022 /PRNewswire/ -- The adhesive bandages market growth is driven by factors such as the growing number of surgical procedures. The prevalence of chronic diseases, such as diabetes, obesity, and cardiovascular diseases, is increasing across the world. Developed countries such as the US, Canada, the UK, Australia, France, and Germany are witnessing a continuous rise in the number of people diagnosed with such diseases owing to changes in lifestyles and eating habits. Diabetes can lead to complications and corrective surgeries if not managed properly. Adhesive bandages can be used for managing diabetic ulcers. Hence, with the rising prevalence of diabetes, the demand for adhesive bandages is expected to increase during the forecast period.
The adhesive bandages market size is expected to grow by USD 622.43 mn from 2021 to 2026. Moreover, the growth momentum of the market will accelerate at a CAGR of 4.26% during the forecast period.
The growing demand for adhesive bandages from ambulatory surgical centers (ASCs) is one of the key trends in the market. Most developed countries such as the US, Canada, the UK, France, and Germany have ASCs, which have modern hospital facilities and offer same-day surgical care. ASCs help patients with cost-effective surgeries, which can be performed in shorter durations. The surgeries can be performed in fully equipped operating rooms. The quality of care delivered in ASCs is considered to be as good as in hospitals. This, in turn, will positively impact the adhesive bandages market growth during the forecast period.
This report segments the adhesive bandages market by product (medicated bandages and non-medicated bandages) and geography (North America, Europe, Asia, and Rest of World (ROW)).
North America will lead the adhesive bandages market during the forecast period. The growth of the region is driven by factors such as advanced healthcare infrastructure. Moreover, market growth in this region will be faster than the growth of the market in Rest of World (ROW). The US and Canada are the key countries for the adhesive bandages market in North America. Prominent vendors in the regional market include 3M Co., Johnson and Johnson Inc., and Cardinal Health Inc. These vendors are launching new and innovative products in the market to expand their market share.
The medicated bandages segment will be the largest revenue-generating product segment during the forecast period. Medicated bandages are also known as first-aid dressings and plasters and consist of an antiseptic solution. These bandages are used to treat superficial injuries, cuts, and bruises and absorb exudate. The medicated bandages segment of the global adhesive bandages market comprises medicated cohesive fabric bandages and medicated flexible fixation bandages. Medicated cohesive fabric bandages can be used to cover wounds. They are also used to provide support to injured muscles and joints. Medicated flexible fixation bandages are used to hold dressings, compresses, and pads in place. These factors will drive the growth of the adhesive bandages segment during the forecast period.
Learn about the contribution of each segment summarized in concise infographics and thorough descriptions. View a FREE PDF Sample Report
North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution
North America at 40%
Key consumer countries
US, Canada, Germany, UK, and China
Competitive landscape
Leading companies, Competitive strategies, Consumer engagement scope
Key companies profiled
3M Co., Argentum Medical LLC, B. Braun SE, Beiersdorf Aktiengesellschaft, Cardinal Health Inc., Coloplast AS, ConvaTec Group Plc, Dynarex Corp., Essity Aktiebolag, Goldwin Medicare Ltd., Integra Lifesciences Holdings Corp., Johnson and Johnson, Lohmann and Rauscher GmbH and Co. KG, Medline Industries Inc., Medtronic Plc, Milliken and Co., Molnlycke Health Care AB, Paul Hartmann AG, Smith and Nephew plc, and Triage Meditech Pvt. Ltd.
Market dynamics
Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and market condition analysis for the forecast period.
Customization purview
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.
Exhibit 101: Cardinal Health Inc. - Business segments
Exhibit 102: Cardinal Health Inc. - Key news
Exhibit 103: Cardinal Health Inc. - Key offerings
Exhibit 104: Cardinal Health Inc. - Segment focus
10.7 ConvaTec Group Plc
Exhibit 105: ConvaTec Group Plc - Overview
Exhibit 106: ConvaTec Group Plc - Product / Service
Exhibit 107: ConvaTec Group Plc - Key news
Exhibit 108: ConvaTec Group Plc - Key offerings
10.8 Dynarex Corp.
Exhibit 109: Dynarex Corp. - Overview
Exhibit 110: Dynarex Corp. - Product / Service
Exhibit 111: Dynarex Corp. - Key offerings
10.9 Johnson and Johnson
Exhibit 112: Johnson and Johnson - Overview
Exhibit 113: Johnson and Johnson - Business segments
Exhibit 114: Johnson and Johnson - Key news
Exhibit 115: Johnson and Johnson - Key offerings
Exhibit 116: Johnson and Johnson - Segment focus
10.10 Medline Industries Inc.
Exhibit 117: Medline Industries Inc. - Overview
Exhibit 118: Medline Industries Inc. - Product / Service
Exhibit 119: Medline Industries Inc. - Key offerings
10.11 Medtronic Plc
Exhibit 120: Medtronic Plc - Overview
Exhibit 121: Medtronic Plc - Business segments
Exhibit 122: Medtronic Plc - Key news
Exhibit 123: Medtronic Plc - Key offerings
Exhibit 124: Medtronic Plc - Segment focus
10.12 Smith and Nephew plc
Exhibit 125: Smith and Nephew plc - Overview
Exhibit 126: Smith and Nephew plc - Business segments
Exhibit 127: Smith and Nephew plc - Key news
Exhibit 128: Smith and Nephew plc - Key offerings
Exhibit 129: Smith and Nephew plc - Segment focus
11 Appendix
11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 130: Inclusions checklist
Exhibit 131: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 132: Currency conversion rates for US$
11.4 Research methodology
Exhibit 133: Research methodology
Exhibit 134: Validation techniques employed for market sizing
Exhibit 135: Information sources
11.5 List of abbreviations
Exhibit 136: List of abbreviations
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...
Amgen and AstraZeneca today announced the results of the Phase 2a COURSE trial evaluating Tezspire® (tezepelumab-ekko) in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of baseline blood...
Emmy-winning actor and St. Louis native Jon Hamm took the stage Saturday, May 18, to offer words of wisdom to the newest graduates of Saint Louis University (SLU) during the University's spring commencement in St. Louis. ...
Nearly 900 undergraduates of the Class of 2024 celebrated their send-off from Bentley University in a very different way than their 2020 arrival amid the COVID-19 pandemic. The 105th undergraduate commencement ceremony was marked by maskless smiles,...
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...